SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Charles River Laboratories International, Inc. – ‘10-Q’ for 6/25/22 – ‘EX-32.1’

On:  Wednesday, 8/3/22, at 3:59pm ET   ·   For:  6/25/22   ·   Accession #:  1100682-22-28   ·   File #:  1-15943

Previous ‘10-Q’:  ‘10-Q’ on 5/4/22 for 3/26/22   ·   Next:  ‘10-Q’ on 11/2/22 for 9/24/22   ·   Latest:  ‘10-Q’ on 11/8/23 for 9/30/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/03/22  Charles River Labs Int’l, Inc.    10-Q        6/25/22   79:9.7M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.15M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
10: R1          Cover Page                                          HTML     75K 
11: R2          Condensed Consolidated Statements of Income         HTML    110K 
                (Unaudited)                                                      
12: R3          Condensed Consolidated Statements of Comprehensive  HTML     60K 
                Income (Unaudited)                                               
13: R4          Condensed Consolidated Balance Sheets (Unaudited)   HTML    163K 
14: R5          Condensed Consolidated Balance Sheets (Unaudited)   HTML     45K 
                (Parenthetical)                                                  
15: R6          Condensed Consolidated Statements of Cash Flows     HTML    126K 
                (Unaudited)                                                      
16: R7          Condensed Consolidated Statements of Changes in     HTML     88K 
                Equity (Unaudited)                                               
17: R8          Basis of Presentation                               HTML     33K 
18: R9          Acquisitions and Divestitures                       HTML    122K 
19: R10         Revenue From Contracts With Customers               HTML     85K 
20: R11         Segment Information                                 HTML    134K 
21: R12         Supplemental Balance Sheet Information              HTML     71K 
22: R13         Venture Capital and Strategic Equity Investments    HTML     27K 
23: R14         Fair Value                                          HTML     86K 
24: R15         Goodwill and Intangible Assets                      HTML     63K 
25: R16         Debt and Other Financing Arrangements               HTML     55K 
26: R17         Equity and Noncontrolling Interests                 HTML     77K 
27: R18         Income Taxes                                        HTML     30K 
28: R19         Restructuring and Asset Impairments                 HTML     40K 
29: R20         Commitments and Contingencies                       HTML     26K 
30: R21         Basis of Presentation (Policies)                    HTML     45K 
31: R22         Acquisitions and Divestitures (Tables)              HTML    118K 
32: R23         Revenue From Contracts With Customers (Tables)      HTML    104K 
33: R24         Segment Information (Tables)                        HTML    163K 
34: R25         Supplemental Balance Sheet Information (Tables)     HTML     82K 
35: R26         Fair Value (Tables)                                 HTML     83K 
36: R27         Goodwill and Intangible Assets (Tables)             HTML     68K 
37: R28         Debt and Other Financing Arrangements (Tables)      HTML     52K 
38: R29         Equity and Noncontrolling Interests (Tables)        HTML     73K 
39: R30         Restructuring and Asset Impairments (Tables)        HTML     39K 
40: R31         Basis of Presentation (Details)                     HTML     24K 
41: R32         ACQUISITIONS AND DIVESTITURES - Narrative           HTML    141K 
                (Details)                                                        
42: R33         ACQUISITIONS AND DIVESTITURES - Purchase Price      HTML    102K 
                Allocation (Details)                                             
43: R34         ACQUISITIONS AND DIVESTITURES - Definite-Lived      HTML     62K 
                Intangible Assets (Details)                                      
44: R35         ACQUISITIONS AND DIVESTITURES - Pro Forma           HTML     29K 
                Information (Details)                                            
45: R36         ACQUISITIONS AND DIVESTITURES - Schedule of         HTML     67K 
                Divestitures (Details)                                           
46: R37         ACQUISITIONS AND DIVESTITURES - Transaction and     HTML     25K 
                Integration Costs (Details)                                      
47: R38         REVENUE FROM CONTRACTS WITH CUSTOMERS -             HTML     45K 
                Disaggregation of Revenues by Major Business Line                
                (Details)                                                        
48: R39         REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule    HTML     51K 
                of Estimated Revenue Related to Performance                      
                Obligations (Details)                                            
49: R40         REVENUE FROM CONTRACTS WITH CUSTOMERS - Narrative   HTML     39K 
                (Details)                                                        
50: R41         REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule    HTML     30K 
                of Client Receivables, Contract Assets and                       
                Contract Liabilities (Details)                                   
51: R42         SEGMENT INFORMATION - Narrative (Details)           HTML     24K 
52: R43         SEGMENT INFORMATION - Revenue and Other Financial   HTML     48K 
                Information by Reportable Segment (Details)                      
53: R44         SEGMENT INFORMATION - Reconciliation of Segment     HTML     38K 
                Operating Income, Depreciation and Amortization,                 
                and Capital Expenditures (Details)                               
54: R45         SEGMENT INFORMATION - Revenue Per Significant       HTML     35K 
                Product or Service (Details)                                     
55: R46         SEGMENT INFORMATION - Summary of Unallocated        HTML     40K 
                Corporate Overhead (Details)                                     
56: R47         SEGMENT INFORMATION - Disaggregation of Revenue by  HTML     39K 
                Geographic Area (Details)                                        
57: R48         Supplemental Balance Sheet Information (Details)    HTML    106K 
58: R49         VENTURE CAPITAL AND STRATEGIC EQUITY INVESTMENTS -  HTML     60K 
                Narrative (Details)                                              
59: R50         FAIR VALUE - Fair Value of Assets and Liabilities   HTML     57K 
                (Details)                                                        
60: R51         FAIR VALUE - Contingent Consideration (Details)     HTML     37K 
61: R52         FAIR VALUE - Narrative (Details)                    HTML     39K 
62: R53         FAIR VALUE - Schedule of Fair Value of Debt         HTML     42K 
                (Details)                                                        
63: R54         GOODWILL AND INTANGIBLE ASSETS - Rollforward of     HTML     38K 
                Goodwill (Details)                                               
64: R55         GOODWILL AND INTANGIBLE ASSETS - Schedule of        HTML     47K 
                Intangible Assets (Details)                                      
65: R56         DEBT AND OTHER FINANCING ARRANGEMENTS - Schedule    HTML     57K 
                of Long-Term Debt (Details)                                      
66: R57         DEBT AND OTHER FINANCING ARRANGEMENTS - Narrative   HTML     44K 
                (Details)                                                        
67: R58         DEBT AND OTHER FINANCING ARRANGEMENTS - Cross       HTML     34K 
                Currency Loans (Details)                                         
68: R59         EQUITY AND NONCONTROLLING INTERESTS - Earnings Per  HTML     64K 
                Share (Details)                                                  
69: R60         EQUITY AND NONCONTROLLING INTERESTS - Narrative     HTML     60K 
                (Details)                                                        
70: R61         EQUITY AND NONCONTROLLING INTERESTS - Accumulated   HTML     63K 
                Other Comprehensive Income (Loss) (Details)                      
71: R62         EQUITY AND NONCONTROLLING INTERESTS - Rollforward   HTML     34K 
                of Redeemable Noncontrolling Interest (Details)                  
72: R63         Income Taxes (Details)                              HTML     38K 
73: R64         RESTRUCTURING AND ASSET IMPAIRMENTS -               HTML     35K 
                Restructuring Costs by Reportable Segment                        
                (Details)                                                        
74: R65         RESTRUCTURING AND ASSET IMPAIRMENTS - Narrative     HTML     25K 
                (Details)                                                        
77: XML         IDEA XML File -- Filing Summary                      XML    144K 
75: XML         XBRL Instance -- crl-20220625_htm                    XML   2.67M 
76: EXCEL       IDEA Workbook of Financial Reports                  XLSX    158K 
 6: EX-101.CAL  XBRL Calculations -- crl-20220625_cal                XML    247K 
 7: EX-101.DEF  XBRL Definitions -- crl-20220625_def                 XML    694K 
 8: EX-101.LAB  XBRL Labels -- crl-20220625_lab                      XML   1.64M 
 9: EX-101.PRE  XBRL Presentations -- crl-20220625_pre               XML   1.02M 
 5: EX-101.SCH  XBRL Schema -- crl-20220625                          XSD    163K 
78: JSON        XBRL Instance as JSON Data -- MetaLinks              418±   633K 
79: ZIP         XBRL Zipped Folder -- 0001100682-22-000028-xbrl      Zip    453K

‘EX-32.1’   —   Certification — §906 – SOA’02

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

 <!   C:   C: 
  Document  

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q for the quarter ended June 25, 2022 of Charles River Laboratories International, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, James C. Foster, Chairman, President and Chief Executive Officer of the Company, and Flavia H. Pease, Corporate Executive Vice President and Chief Financial Officer of the Company, each hereby certifies, to the best of his knowledge and pursuant to 18 U.S.C. Section 1350, that:
(1)    the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”); and
(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ James C. Foster
August 3, 2022
Chairman, President and Chief Executive Officer
Charles River Laboratories International, Inc.
/s/ Flavia H. Pease
August 3, 2022

Corporate Executive Vice President and Chief Financial Officer
Charles River Laboratories International, Inc.

This certification shall not be deemed "filed" for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/3/228-K
For Period end:6/25/22
 List all Filings 
↑Top
Filing Submission 0001100682-22-000028   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 11:09:28.2am ET